DocWire News Editors

DocwireNews

A recent study detailed a process to provide palliative care simultaneously with a phase one clinical trial, the results of which were shared in a poster presentation during the <a href="https://ons.confex.com/ons/2019/meetingapp.cgi/Index/ePoster~1/Program/1033">Oncology Nursing Society 44th Annual Congress</a>.
When patients exhaust their treatment options, they usually have three choices: enrollment in a clinical trial, a palliative care program, or hospice. Those who enroll in phase one trials typically have a projected survival of five to nine months, and a 3.8-10.6% response rate to investigational products. Because many patients choose to continue with their directed treatment regimen, they do not take part in advanced care planning discussions. Palliative care teams are able to not only transition patients from their usual treatment to investigational treatment, but also from investigational treatment to end of life care at the conclusion of the patient’s study participation. A patient’s quality of life (QoL) is not often considered: QoL was only considered a study’s endpoint in 2% of phase one trials. There are currently no data on palliative care’s impact on this population.
Including palliative care in the clinical trial enrollment process could help bridge the gap between research and clinical care. Potential positive outcomes with this approach include:
<ul>
<li>Reduce some of the clinical investigator’s burden</li>
<li>Improve patients’ QoL</li>
<li>Reduce End of Life care costs</li>
<li>Increase the number of patients enrolled in the trial who have advanced care planning discussions</li>
<li>Provide post-trial continuity</li>
<li>Extend life expectancy</li>
<li>Prolong length on trial</li>
<li>Achieve high rates of advance directive completion</li>
<li>More likely to die comfortably at home</li>
</ul>
Because the majority of phase one clinical trials take place in medical centers—where a palliative care team is available—it would be possible to refer these patients to palliative care automatically.
 
Brock A. The Role of Palliative Care in Phase 1 Clinical Trial Participants.

A recent study detailed a process to provide palliative care simultaneously with a phase one clinical trial, the results of which were shared in a poster presentation during the <a href="https://ons.confex.com/ons/2019/meetingapp.cgi/Index/ePoster~1/Program/1033">Oncology Nursing Society 44th Annual Congress</a>.When patients exhaust their treatment options, they usually have three choices: enrollment in a clinical trial, a palliative care program, or hospice. Those who enroll in phase one trials typically have a projected survival of five to nine months, and a 3.8-10.6% response rate to investigational products. Because many patients choose to continue with their directed treatment regimen, they do not take part in advanced care planning discussions. Palliative care teams are able to not only transition patients from their usual treatment to investigational treatment, but also from investigational treatment to end of life care at the conclusion of the patient’s study participation. A patient’s quality of life (QoL) is not often considered: QoL was only considered a study’s endpoint in 2% of phase one trials. There are currently no data on palliative care’s impact on this population.Including palliative care in the clinical trial enrollment process could help bridge the gap between research and clinical care. Potential positive outcomes with this approach include:<ul>
<li>Reduce some of the clinical investigator’s burden</li>
<li>Improve patients’ QoL</li>
<li>Reduce End of Life care costs</li>
<li>Increase the number of patients enrolled in the trial who have advanced care planning discussions</li>
<li>Provide post-trial continuity</li>
<li>Extend life expectancy</li>
<li>Prolong length on trial</li>
<li>Achieve high rates of advance directive completion</li>
<li>More likely to die comfortably at home</li>
</ul>Because the majority of phase one clinical trials take place in medical centers—where a palliative care team is available—it would be possible to refer these patients to palliative care automatically. Brock A. The Role of Palliative Care in Phase 1 Clinical Trial Participants.

Anne Marie Morse, DO

Rob Dillard

AI in Sleep Medicine: Augmenting Care, Not Replacing It

Sleep Disorders

Jordana Jampel

Real-World Data Support Tofacitinib for Ulcerative Colitis

Gastroenterology

Debra Patt, MD, PhD, MBA

ePROs and the Future of Cancer Care: Real-World Lessons From OncoPRO

Breast Cancer News

Latest News

Challenges and Pathways to Simultaneous Clinical Trial and Palliative Care Enrollment

Spring 2019 Conference coverage

A recent study detailed a process to provide palliative care simultaneously with a phase one clinical trial, the results of which were shared in a poster presentation during ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Diabetes

Obesity

Metabolic Care Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe